Web Analytics
หุ้น HAE (NYSE) | HAEMONETICS CORPORATION – วิเคราะห์โดย Deepscope
MARKET

Select Market Data Region

HAE — HAEMONETICS CORPORATION (Healthcare >> Medical Devices)

HAE FAQ

What is HAE's P/E ratio?

HAEMONETICS CORPORATION (HAE) currently trades at a P/E ratio of 28.05.

What is HAE's ROE?

HAEMONETICS CORPORATION reports a Return on Equity (ROE) of 12.22%.

What is HAE's dividend yield?

HAEMONETICS CORPORATION offers a dividend yield of 0.00%.

What is HAE's Deepscope Quality Score?

Deepscope rates HAE's overall financial quality at 38 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy HAE?

Deepscope's AI Timing Score for HAE is 91 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does HAE belong to?

HAEMONETICS CORPORATION is classified under the Healthcare >> Medical Devices sector on the NYSE exchange.

Stock Check   *ข้อมูลอัปเดตรายวัน ที่เวลา 09.30 น.*
(Price: 2026-06-05 | FS: 2026-03-31)

HAE

HAEMONETICS CORPORATION
USD 71.28
1.43 (2.05%) Day Change
28.05
P/E
1.54
D/E
12.2%
ROE
4.1%
ROA
0.00%
Div Yield
1.21
PEG
USD 71.28
Price
1.43 (2.05%)
Day Change
NEWS SCORE: 99

HAE มีคุณภาพโดยรวมไม่ดี ( คะแนนปัจจัยพื้นฐาน = 38) แต่ จังหวะเข้าซื้อ ...(ล็อกอินเพื่อดู)...

38

QUALITY

Signal
UNDERPERFORM
Signal Description
Company financial health is Not Good
Reason
อัตราผลตอบแทนผู้ถือหุ้น (ROE) ค่อนข้างต่ำ
อัตราเร่งของการเติบโตของอัตราผลตอบแทนผู้ถือหุ้น (ROE) ต่ำกว่าเกณฑ์
อัตราผลตอบแทนผู้ถือหุ้น (ROE) ลดลงอย่างมีนัยยะสำคัญ
อัตราผลตอบแทนสินทรัพย์ (ROA) ค่อนข้างต่ำเมื่อเทียบกับอัตราผลตอบแทนผู้ถือหุ้น(ROE)
อัตราเร่งของการเติบโตของอัตราผลตอบแทนสินทรัพย์ (ROA) ต่ำกว่าเกณฑ์
อัตรากำไรสุทธิ ค่อนข้างต่ำ
อัตราเร่งของการเติบโตของอัตรากำไรสุทธิ ต่ำกว่าเกณฑ์
อัตรากำไรสุทธิในอดีต ค่อนข้างต่ำ

88 Sign in

TIMING

Signal
OUTPERFORM
Signal Descri...
Good
Reason
Lorem ipsum dolor sit amet
Sign in to see timing analysis
Unlock timing signals and detailed reasons
Sign in free

ถ้าดูอย่างละเอียดจะพบว่า ปัจจัยทางคุณภาพ ไม่ดี สุขภาพทางการเงิน ไม่ดี และ ประสิทธิภาพการทำกำไร พอใช้ , ...

ปัจจัยทางคุณภาพ 48%
X
X
X
X
  In Recommendations? Not in any sections
  Select Rate 0.00 From 30 days period
  Watch Rate 0.00 From 30 days period
  News Score 99
  Magic Formula Rank by ROA
1596
  Magic Formula Rank by ROE
1596
  Magic Formula Rank by ROIC
1622
  Price 71.28
  PBV / Sector
4.14 / 7.50
  Earning Per Share 2.05
  PE / Sector
28.05 / 29.01
  PEG or PE/Growth / Sector
1.21 / 0.39
  Average 1M Daily Value
59.08 M
  Average 1W Daily Value
57.53 M
ปัจจัยทางเทคนิค 85%
  MACD
  MACD Signal
  MACD Divergence
  RSI
  Stochastic Oscillator K
  Stochastic Oscillator D
  ADX
  Avg 5 day Timing Score
สุขภาพทางการเงิน 45%
X
X
X
X
  DE / Sector
  DE Average / Sector
  DE Change Average (%) / Sector
  Current Ratio / Sector
  Current Ratio Average / Sector
  Current Ratio Change Average (%) / Sector
  Quick Ratio / Sector
  Quick Ratio Average / Sector
  Quick Ratio Change Average (%) / Sector
  FCF/Share / Sector
  FCF/Share Average / Sector
  FCF/Share Change Average (%) / Sector
ประสิทธิภาพการทำกำไร 62%
X
X
X
X
X
X
X
  GPM (%) / Sector
  GPM Average (%) / Sector
  GPM Change Average (%) / Sector
  OPM (%) / Sector
  OPM Average (%) / Sector
  OPM Change Average (%) / Sector
  NPM (%) / Sector
7.29 / 20.12
  NPM Average (%) / Sector
9.62 / -15.01
  NPM Change Average (%) / Sector
-4.22 / 2.65
  Asset Turnover / Sector
  Asset Turnover Average / Sector
  Asset Turnover Change Average (%) / Sector
  ROA (%) / Sector
4.06 / 11.02
  ROA Average (%) / Sector
5.56 / -0.05
  ROA Change Average (%) / Sector
-7.70 / 7.12
  ROE (%) / Sector
12.22 / 42.27
  ROE Average (%) / Sector
14.75 / 24.22
  ROE Change Average (%) / Sector
4.48 / 0.94
  ROIC (%) / Sector
  ROIC Average (%) / Sector
  ROIC Change Average (%) / Sector
ผลตอบแทนต่อผู้ถือหุ้น 4%
X
  Dividend (%) / Sector
N/A / 0.48
  Dividend Average (%) / Sector
N/A / 1.89
  Dividend Change Average (%) / Sector
N/A / 6.53
รายละเอียดการจดทะเบียน
X
  Analyze Date 2026-06-06 09:08:42
  Symbol HAE
  Name HAEMONETICS CORPORATION
  Sector Healthcare >> Medical Devices
  Market NYSE
  Listed Shares 45.45 M
  Par Value N/A
  Calculated From YearEnd
  Sign N/A
  Market Cap (M.USD) / Sector Average 3,294.85 / 18,389.26
ข่าว, ประมาณการ, ...
  Estimation Consensus See at WSJ.com
  Full details See at WSJ.com
  Chart See in Chart feature
  News See at Yahoo Finance

Address: 125 Summer Street, Boston, MA, United States, 02110

Phone: 781 848 7100

Website: https://www.haemonetics.com

Employees: 3,009

Sector: Healthcare >> Medical Devices

Description: Haemonetics Corporation, a medical technology company, provides a suite of hospital technologies solutions. The company operates through Plasma, Blood Center, and Hospital segments. It provides automated plasma collection systems, donor management software, and supporting software solutions, such as NexSys PCS plasmapheresis equipment system and related disposables and solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system and Donor360 tools. The company also offers treatment in electrophysiology, critical care, neurocritical care, trauma, burn surgery, spine surgery, and cancer surgery; SavvyWire, a sensor-guided 3-in-1 guidewire for TAVR procedures; and OptoWire, a pressure guidewire that measures fractional flow reserve and diastolic pressure ratio, as well as fiber optic sensor solutions used in medical devices and other critical industrial applications. In addition, it provides hospital products comprising TEG 6s system, smallest cartridge-based viscoelastic analyzer that provides a comprehensive assessment of a patient's overall hemostasis; and TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions. Further, the company offers Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries;vascular closure products comprise VASCADE 5F, VASCADE 6/7F, VASCADE MVP XL, and VASCADE MVP, a technology platform which offers catheter-based delivery system and leverages the natural clot-inducing properties of collagen; and transfusion management solutions. It sells its products through direct sales force and independent distributors. The company was founded in 1971 and is headquartered in Boston, Massachusetts.

ME vs SECTOR Healthcare >> Medical Devices

HAE (ME)
Sector Peers
Bubble size = Market Cap

Click a bubble to view stock details  ·  Bubble size represents market capitalization share

News

Smart picks. Just WOW stocks/funds/ETFs. No noise like other tools.
HAE
HAE
USD 71.28 (2.05%)
+ Watch + Port Chart